HealWELL AI Inc.

Healthcare CA AIDX

1.32CAD
0.01(0.76%)

Last update at 2025-07-04T16:43:00Z

Day Range

1.291.36
LowHigh

52 Week Range

1.092.56
LowHigh

Fundamentals

  • Previous Close 1.31
  • Market Cap382.19M
  • Volume98898
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-39.44400M
  • Revenue TTM48.48M
  • Revenue Per Share TTM0.32
  • Gross Profit TTM 21.46M
  • Diluted EPS TTM-0.21

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -32.68300M -17.07600M -16.28800M -1.33900M -0.03000M
Minority interest - - - - -
Net income -32.19300M -21.08500M -15.67000M -1.02900M -0.12200M
Selling general administrative 9.06M 11.36M 30.18M 13.61M 13.53M
Selling and marketing expenses 1.28M 1.52M 1.11M 0.12M -
Gross profit 1.26M 3.71M 15.01M 64.22M 15.26M
Reconciled depreciation - - - - -
Ebit -17.59200M -17.54800M -16.43400M -0.84200M 0.52M
Ebitda -16.11300M -15.00800M -12.12500M 2.11M 3.64M
Depreciation and amortization 1.48M 2.54M 4.31M 2.96M 3.12M
Non operating income net other - - - - -
Operating income -17.59200M -17.54800M -16.43400M -0.84200M 0.52M
Other operating expenses 38.66M 27.74M 64.26M 11.91M 47.58M
Interest expense - 0.62M 0.46M 0.50M 0.54M
Tax provision - 1.22M -0.74700M -0.31200M -
Interest income - 1.03M 0.35M 0.06M -
Net interest income - - - - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.54M 1.12M -0.74700M -0.31200M 0.09M
Total revenue 7.32M 10.42M 47.82M 38.57M 46.29M
Total operating expenses 32.60M 21.03M 31.45M 13.74M 16.55M
Cost of revenue 6.06M 6.71M 32.81M -25.64900M 31.03M
Total other income expense net -15.09100M 0.88M 0.64M 0.02M 1.85M
Discontinued operations - - - - -
Net income from continuing ops - - - - -
Net income applicable to common shares - -21.08500M -15.67000M -1.02900M -
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 125.53M 53.70M 45.63M 60.89M 22.36M
Intangible assets 28.30M 12.51M 11.25M 12.45M 0.49M
Earning assets - - - - -
Other current assets 2.35M 2.35M 1.17M 2.50M 0.87M
Total liab 51.86M 32.23M 33.85M 32.86M 22.24M
Total stockholder equity 63.89M 12.65M 11.78M 28.03M 0.11M
Deferred long term liab - - - - -
Other current liab 13.43M 4.82M - - -
Common stock 140.08M 67.37M 39.79M 39.79M 1.01M
Capital stock 140.08M - - - -
Retained earnings -95.21800M -69.24900M -37.65200M -16.56700M -0.89700M
Other liab - - - - -
Good will 67.14M 12.30M 10.07M 10.07M 0.15M
Other assets - - 0.47M 1.95M 1.06M
Cash 9.41M 19.16M 1.41M 7.14M 0.89M
Cash and equivalents - - - - -
Total current liabilities 23.32M 9.42M 19.39M 14.49M 10.74M
Current deferred revenue 2.45M - - - -
Net debt 12.79M 0.76M - - -
Short term debt 2.73M 0.67M 7.00M 0.00000M 1.21M
Short long term debt 1.78M - - - -
Short long term debt total 22.20M 19.92M - - -
Other stockholder equity 19.02M 12.57M - - -
Property plant equipment - - 10.44M 13.93M 13.57M
Total current assets 18.33M 22.76M 8.61M 16.51M 5.78M
Long term investments 4.48M - - - -
Net tangible assets - - - - -
Short term investments 0.27M - 0.39M 0.54M 0.38M
Net receivables 6.29M 1.24M 4.29M 3.22M 2.21M
Long term debt 14.24M - - - -
Inventory - - - - -
Accounts payable 4.33M 3.93M - - -
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -0.00300M 1.96M - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 2.37M 1.99M - - -
Deferred long term asset charges - - - - -
Non current assets total 107.21M 30.94M - - -
Capital lease obligations 6.18M - - - -
Long term debt total - - 9.33M 11.26M 11.30M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments - - - - -
Change to liabilities - - - - -
Total cashflows from investing activities - -1.16800M -8.64400M -0.23400M -
Net borrowings - - - - -
Total cash from financing activities 27.20M 3.78M 21.99M -4.22200M -2.89100M
Change to operating activities - - - - -
Net income -31.59700M -20.97000M -15.54100M -1.02700M -0.12000M
Change in cash 17.75M -5.73100M 6.25M -0.23400M 0.20M
Begin period cash flow 1.41M 7.14M 0.89M 1.13M 0.93M
End period cash flow 19.16M 1.41M 7.14M 0.89M 1.13M
Total cash from operating activities -10.79800M -8.34600M -7.09800M 4.22M 3.21M
Issuance of capital stock - - - - -
Depreciation 2.80M 2.54M 4.31M 2.96M 3.12M
Other cashflows from investing activities - 0.00000M -6.27600M - -
Dividends paid - 0.12M 0.00000M 2.01M -
Change to inventory - - - - -
Change to account receivables 4.51M 0.69M -1.50400M -1.21900M 0.16M
Sale purchase of stock - 0.00000M -0.87000M - -
Other cashflows from financing activities 27.60M -0.11600M -1.38100M -0.04300M -0.31000M
Change to netincome - - - - -
Capital expenditures 0.07M 1.15M 2.37M 0.23M 0.12M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 4.56M 2.21M -1.64800M 1.73M -0.66400M
Stock based compensation 3.26M 4.83M 6.11M 0.75M -
Other non cash items 10.18M -1.13600M -0.23100M 0.04M 0.46M
Free cash flow -10.86400M -9.49400M -9.46600M 3.99M 3.09M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AIDX
HealWELL AI Inc.
0.01 0.76% 1.32 - - 7.52 4.09 9.29 -4.9271
SIA
Sienna Senior Living Inc
0.12 0.64% 18.80 45.24 28.25 1.91 2.77 2.85 18.97
DNTL
dentalcorp Holdings Ltd
0.03 0.36% 8.30 - 16.18 1.01 0.90 1.84 13.06
EXE
Extendicare Inc
-0.08 0.58% 13.69 15.91 17.83 0.80 9.43 0.92 8.69
WELL
WELL Health Technologies Corp
0.01 0.35% 4.25 - 10.92 1.00 1.19 1.38 20.27

Reports Covered

Stock Research & News

Profile

Healwell AI Inc., a healthcare artificial intelligence company, develops and commercializes clinical decision support systems in Canada, New Zealand, Australia, and the United Kingdom. The company operates through three segments: Clinical Research and Patient services, AI and Data Sciences, and Healthcare Software. It also provides AI-driven healthcare information analytics and insights, technology-enabled chronic disease screening, electronic health record software and healthcare data management services, pulmonary function testing lab services, clinical research services, and medical consultation services to patients, as well as primary and specialty healthcare services. In addition, the company engages in the business of evidence-clinical study generation, clinical decision support, and physical ASI co-pilot tools. Further, it provides early-stage bioanalysis and phase I-IV service through its medical clinics, telehealth, and virtual care platform. It serves pharmaceutical and life sciences firms, precision medicine pioneers, healthcare providers, and hospitals. Healwell AI Inc. has a strategic alliance agreement with WELL Health Technologies Corp to enhance the growth and development of AI-enabled healthcare technologies. The company was formerly known as MCI Onehealth Technologies Inc. and changed its name to Healwell AI Inc. in October 2023. Healwell AI Inc. was incorporated in 2012 and is headquartered in Toronto, Canada.

HealWELL AI Inc.

460 College Street, Toronto, ON, Canada, M6G 1A1

Key Executives

Name Title Year Born
Mr. Donald Watts President of Khure Health NA
Dr. Alexander Julian Dobranowski Founder, CEO, MD & Director NA
Ms. Madeline D. Walker President of MCI Medical 1947
Mr. Anthony Lam Chief Financial Officer NA
Paulo Gomes Co-Chief Operating Officer NA
Adam Hutton Co-Chief Operating Officer NA
Nolan Reeds Vice President of Marketing & Communications NA
Mr. Blake Corbet Senior Vice President of Corporate Development NA
Mr. Mark Findlay Senior Vice President of Sales & Marketing for Canada NA
Aaron Leibtag Pentavere Research Group -CEO NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.